申请人:Minerva Biotechnologies Corporation
公开号:EP2320231A2
公开(公告)日:2011-05-11
The invention provides novel techniques for derivatizing colloids with self-assembled monolayers. This provides the capability of a wide variety of assays including chemical or biochemical agent/agent interaction studies. Bio-derivatized colloids, with or without signaling entities, are used to probe interactions with species on non-colloidal structures. The invention provides techniques for immobilizing colloidal particles on a wide variety of non-colloidal structures. Included is the ability to decorate a variety of non-colloidal structures including beads, with colloids as a detectable assay. This allows, in many cases, assays detectable via the unaided human eye, as well as assays detectable via automated determination of a change of interaction of electromagnetic radiation with the colloids, e.g., absorption, light-scattering, and the like.
本发明提供了用自组装单层衍生胶体的新技术。这提供了多种检测能力,包括化学或生化制剂/制剂相互作用研究。含有或不含信号实体的生物衍生胶体可用于探测与非胶体结构上物种的相互作用。本发明提供了将胶体颗粒固定在各种非胶体结构上的技术。其中包括用胶体装饰包括珠子在内的各种非胶体结构,作为一种可检测的化验方法。这样,在许多情况下,既可以通过辅助人眼进行检测,也可以通过自动测定电磁辐射与胶体相互作用的变化(如吸收、光散射等)进行检测。